Canadian guidelines on sexually transmitted infections : treatment of N. gonorrhoeae in response to the discontinuation of spectinomycin : alternative treatment guidance statement.: HP40-1/2017-3-1E-PDF
"The Public Health Agency of Canada (PHAC) has been informed that manufacturing of spectinomycin has been discontinued. Spectinomycin is recommended in the Canadian Guidelines on Sexually Transmitted Infections (CGSTI) as part of an alternate combination therapy for anogenital Neisseria gonorrhoeae infection, in individuals with contraindications to first-line treatment (i.e., cephalosporins given in combination with azithromycin or doxycycline). This guidance statement for alternative treatments for gonococcal infections was developed in consultation with the CGSTI Expert Working Group based on Canadian epidemiology and a rapid evidence review”--Issue, p. 1.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.840166&sl=0
| Department/Agency | Public Health Agency of Canada. |
|---|---|
| Title | Canadian guidelines on sexually transmitted infections : treatment of N. gonorrhoeae in response to the discontinuation of spectinomycin : alternative treatment guidance statement. |
| Variant title | Treatment of N. gonorrhoeae in response to the discontinuation of spectinomycin : alternative treatment guidance statement |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Earlier edition | Canadian guidelines on sexually transmitted infections |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Lignes directrices canadiennes sur les infections transmissibles sexuellement. Traitement des infections gonococciques par suite du retrait du marché de la spectinomycine : déclaration d’orientation pour les traitements de remplacement. Caption title. Includes bibliographical references. |
| Publishing information | [Ottawa] : Public Health Agency of Canada, 2017. |
| Description | 4 p. |
| ISBN | 978-0-660-09142-6 |
| Catalogue number |
|
| Departmental catalogue number | 170170 |
| Edition | Revised July 2017. |
| Subject terms | Sexually transmitted diseases Medicine Guidelines |